Nobilis Therapeutics receives NIH Award

Nobilis Therapeutics, a clinical stage biotechnology company focused on advancement of innovative CNS therapies, announced today the receipt of a $320K Phase I Small Business Technology Transfer Grant (STTR) from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH). The sponsored research will test the effects of the company’s proprietary […] [Read More]

—–
Source: Weekly Blitz :: Writings


« Previous Post
Next Post »
 

Comments are closed. Please check back later.

 
 
 
1